Neuron23
PrivateLast Round
Series D
Jun 24, 2025
Total Funding Raised
$310M
Momentum Score
25 /100
Company Overview
Neuron23 is a biotechnology company that develops an AI-driven drug discovery platform aimed at creating therapeutics for genetically defined neurological and immunological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuron23 Comps
Public and private peers based on sector, stage, and business model.
Neuron23 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 24, 2025 | ||||
| Series C | Mar 30, 2022 | ||||
| Series B | Dec 16, 2020 | ||||
| Series A | Dec 16, 2020 |
Key People
Founding team and executive leadership
Neuron23 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series D, Series B |
| SoftBank Investment Advisers | Series C |
| Westlake Village Biopartners | Series D, Series C, Series B, Series A |
| Perceptive Advisors | Series C, Series B |
| TD Securities | Series C, Series B |
| Blue Owl Capital | Series D |
| SoftBank Vision Fund 2 | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2025
NEULARK trial targets LRRK2 gene overactivity.
- Jun 25, 2025
Partnered with Sano Genetics for subject referrals and participant identification.
Neuron23 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuron23's valuation, stock price, and market status.
